Our in vitro observations further suggested that stroke-induced elevations in circulating sCD163 have the capacity to elicit direct suppressive effects on the adaptive immune system, as depletion of sCD163 from ischemic stroke patient-derived serum was able to partially rescue its capacity to support lymphocyte proliferation. The gene discussed is CD163; the disease is Stroke.